Literature DB >> 15467363

A role for the MutL homologue MLH2 in controlling heteroduplex formation and in regulating between two different crossover pathways in budding yeast.

M F F Abdullah1, E R Hoffmann, V E Cotton, R H Borts.   

Abstract

BACKGROUND AND AIMS: Mismatch repair proteins play important roles during meiotic recombination in the budding yeast Saccharomyces cerevisiae and most eukaryotic organisms studied to date. To study the functions of the mismatch repair protein Mlh2p in meiosis, we constructed mlh2Delta strains and measured rates of crossing over, gene conversion, post-meiotic segregation and spore viability. We also analysed mlh1Delta, mlh3Delta, msh4Delta, msh5Delta, exo1Delta and mus81Delta mutant strains singularly and in various combinations.
RESULTS: Loss of MLH2 resulted in a small but significant decrease in spore viability and a significant increase in gene conversion frequencies but had no apparent effect on crossing over. Deletion of MLH2 in mlh3Delta, msh4Delta or msh5Delta strains resulted in significant proportion of the "lost" crossovers found in single deletion strains being regained in some genetic intervals. We and others propose that there are at least two pathways to generate crossovers in yeast (Ross-Macdonald and Roeder, 1994; Zalevsky et al., 1999; Khazanehdari and Borts, 2000; Novak et al., 2001; de los Santos et al., 2003). Most recombination intermediates are processed by the "major", Msh4-dependent pathway, which requires the activity of Mlh1p/Mlh3p/Msh4p/Msh5p as well as a number of other proteins. The minor pathway(s) utilizes Mms4p/Mus81p. We suggest that the absence of Mlh2p allows some crossovers from the MSH4 pathway to traverse the MUS81-dependent pathway. Copyright 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15467363     DOI: 10.1159/000080596

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  22 in total

1.  A two-pathway analysis of meiotic crossing over and gene conversion in Saccharomyces cerevisiae.

Authors:  Franklin W Stahl; Henriette M Foss
Journal:  Genetics       Date:  2010-08-02       Impact factor: 4.562

Review 2.  Processing of joint molecule intermediates by structure-selective endonucleases during homologous recombination in eukaryotes.

Authors:  Erin K Schwartz; Wolf-Dietrich Heyer
Journal:  Chromosoma       Date:  2011-01-11       Impact factor: 4.316

3.  Mispair-specific recruitment of the Mlh1-Pms1 complex identifies repair substrates of the Saccharomyces cerevisiae Msh2-Msh3 complex.

Authors:  Anjana Srivatsan; Nikki Bowen; Richard D Kolodner
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

4.  Distinct regulation of Mlh1p heterodimers in meiosis and mitosis in Saccharomyces cerevisiae.

Authors:  Victoria E Cotton; Eva R Hoffmann; Rhona H Borts
Journal:  Genetics       Date:  2010-04-09       Impact factor: 4.562

5.  MLH1 and MSH2 promote the symmetry of double-strand break repair events at the HIS4 hotspot in Saccharomyces cerevisiae.

Authors:  Eva R Hoffmann; Emma Eriksson; Benjamin J Herbert; Rhona H Borts
Journal:  Genetics       Date:  2005-01-16       Impact factor: 4.562

Review 6.  A personal historical view of DNA mismatch repair with an emphasis on eukaryotic DNA mismatch repair.

Authors:  Richard D Kolodner
Journal:  DNA Repair (Amst)       Date:  2015-12-03

7.  Analysis of the proteins involved in the in vivo repair of base-base mismatches and four-base loops formed during meiotic recombination in the yeast Saccharomyces cerevisiae.

Authors:  Jana E Stone; Thomas D Petes
Journal:  Genetics       Date:  2006-05-15       Impact factor: 4.562

8.  Does crossover interference count in Saccharomyces cerevisiae?

Authors:  Franklin W Stahl; Henriette M Foss; Lisa S Young; Rhona H Borts; M F F Abdullah; Gregory P Copenhaver
Journal:  Genetics       Date:  2004-09       Impact factor: 4.562

9.  CDKG1 Is Required for Meiotic and Somatic Recombination Intermediate Processing in Arabidopsis.

Authors:  Candida Nibau; Andrew Lloyd; Despoina Dadarou; Alexander Betekhtin; Foteini Tsilimigka; Dylan W Phillips; John H Doonan
Journal:  Plant Cell       Date:  2020-02-10       Impact factor: 11.277

Review 10.  ATR/CHK1 inhibitors and cancer therapy.

Authors:  Zhaojun Qiu; Nancy L Oleinick; Junran Zhang
Journal:  Radiother Oncol       Date:  2017-10-18       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.